BioSpace News Archive

Ipsen Announces Positive Topline Results From Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX ® (cabozantinib) in Combination with Opdivo® (nivolumab) in Previously Untreated Advanced Renal Cell Carcinoma Study met primary endpoint of significantly improving progression-free survival, and secondary endpoints of overall survival and objective response rate vs. sunitinib CABOMETYX in combination with Opdivo demonstrates clinically m

ELITechGroup MDx LLC, a leading global provider of diagnostic testing products, and its Korean partner, OSANG Healthcare, announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its SARS-CoV-2 virus test for use in the United States .

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first-quarter 2020 financial results on Wednesday, April 29, 2020 after the financial markets close. The company will host a conference call and webcast at 5:00 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The conference call will be webcast live and a link to the webcast can be accessed through Verte

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Optoelectronics and Manufacturing division has received an order for approximately $8 million to provide electronic sub-assemblies for a leading healthcare original equipment manufacturer (OEM). OSI Systems’ Chairman and Chief Executive Officer, Deepak Chopra, stated, “We

CipherHealth, the leading patient engagement technology company, has named Chris Aulbach Chief Product Officer (CPO) and Jim Somers as their new Chief Marketing Officer (CMO).

First Response™ remains committed in supporting RESOLVE: The National Infertility Association’s 2020 National Infertility Awareness Week (NIAW), a week-long movement from April 19-25 to change the conversation around the challenges 1 in 8 couples face in building a family

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has commenced production of a sample collection and transport kit, comprised of a nasopharyngeal swab and transport vial, used to collect specimens with suspected presence of Coronavirus Disease 2019 (COVID-19). The kit will be produced at Merit’s fa

Swedish Orphan Biovitrum AB (publ) (Sobi™) hereby informs that the shareholders may exercise their voting rights at the 2020 annual general meeting by voting in advance, so-called postal voting. Sobi urges shareholders to exercise this option in order to minimize the number of participants who attend the general meeting in person. S

The COVID 19 pandemic is creating a substantial paradigm shift in how we live and work, swiftly changing the business ecosystem

SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates inhibit the main protease of SARS-CoV-2 and therefore the replication of the virus. Clinical studies with the three candidates can be initiated immediately.